62 Lygon Street
Carlton, VIC 3053
61 3 9824 5254
|Mr. Paul Edward-Alexander Hopper A.S.i.A, B.A (UNSW), FAICD||Founder & Exec. Chairman||291.04k||N/A||1956|
|Mr. Riccardo Canevari||MD, CEO & Director||2.06M||N/A||N/A|
|Mr. Phillip Hains||CFO & Company Sec.||N/A||N/A||N/A|
|Prof. David Mozley||Chief Medical Officer & Scientific Advisory Board Chair||860.77k||N/A||N/A|
|Mr. Vittorio Puppo M.D.||Chief Operating Officer||N/A||N/A||N/A|
|Dr. Thomas H. Tulip Ph.D.||Chief Technical Officer||N/A||N/A||1953|
|Dr. Scot L. Harper Ph.D.||Sr. VP of Clinical Operations||N/A||N/A||1957|
|Mr. Bill Regan||Sr. VP of Regulatory Strategy||N/A||N/A||N/A|
|Dr. Rama Abu Shmeis||Sr. VP of Chemistry, Manufacturing & Controls||N/A||N/A||N/A|
|Mr. Nathan Jong C.A.||Company Sec.||N/A||N/A||N/A|
Radiopharm Theranostics Limited develops radiopharmaceutical products for diagnostic and therapeutic uses. The company was incorporated in 2021 and is based in Carlton, Australia.
Radiopharm Theranostics Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.